Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
April 03, 2014
February 26, 2014
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
January 13, 2014
Geneticists from Ohio, California and Japan used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to correct chromosome abnormalities that give rise to birth defects, mental disabilities and growth limitations.
January 09, 2014
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
August 19, 2013
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
June 03, 2013
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center today announced the formation of the Oncology Innovation Alliance (OIA), a public-private partnership focusing on the discovery and development of novel therapies and their potential role in treating various types of hematologic cancers and solid tumors.